Mammary Neoplasms
|
0.400 |
Biomarker
|
group |
BEFREE |
Breast cancer resistance protein (BCRP) is an ATP-binding cassette transporter that facilitates the efflux of various anticancer drugs from the cell and cause MDR phenotype in breast tumors.
|
28282800 |
2017 |
Mammary Neoplasms
|
0.400 |
Biomarker
|
group |
CTD_human |
BCRP/MXR/ABCP expression in topotecan-resistant human breast carcinoma cells.
|
10930538 |
2000 |
Mammary Neoplasms
|
0.400 |
AlteredExpression
|
group |
LHGDN |
Co-expression of cytokeratin 8 and breast cancer resistant protein indicates a multifactorial drug-resistant phenotype in human breast cancer cell line.
|
18725232 |
2008 |
Mammary Neoplasms
|
0.400 |
AlteredExpression
|
group |
LHGDN |
Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia.
|
18200595 |
2008 |
Mammary Neoplasms
|
0.400 |
Biomarker
|
group |
LHGDN |
Doxorubicin transport by RALBP1 and ABCG2 in lung and breast cancer.
|
17273774 |
2007 |
Mammary Neoplasms
|
0.400 |
AlteredExpression
|
group |
LHGDN |
Expression and localisation of breast cancer resistance protein (BCRP) in human fetal membranes and decidua and the influence of labour at term.
|
18255023 |
2008 |
Mammary Neoplasms
|
0.400 |
AlteredExpression
|
group |
BEFREE |
Four MDR genes: ABCB1, ABCC1, ABCC2 and ABCG2 were shown to form the functional expression cluster in breast tumor.
|
28601971 |
2017 |
Mammary Neoplasms
|
0.400 |
Biomarker
|
group |
BEFREE |
In particular, we analysed the association of NAC response and pre- and post-NAC expression of the main multidrug resistance (MDR) genes--ABCB1, ABCC1, ABCC5, ABCG1, and ABCG2, with the presence of different morphological structures in breast tumors.
|
24736530 |
2014 |
Mammary Neoplasms
|
0.400 |
Biomarker
|
group |
LHGDN |
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).
|
14576842 |
2003 |
Mammary Neoplasms
|
0.400 |
GeneticVariation
|
group |
LHGDN |
Single amino acid substitutions in the transmembrane domains of breast cancer resistance protein (BCRP) alter cross resistance patterns in transfectants.
|
14566825 |
2003 |
Mammary Neoplasms
|
0.400 |
GeneticVariation
|
group |
BEFREE |
To test this hypothesis, we used real-time quantitative RT-PCR to quantify the mRNA expression of a large panel of genes coding for the major xenobiotic-metabolizing enzymes (12 phase I enzymes, 12 phase II enzymes and three members of the ABC transporter family) in a small series of normal breast (and liver) tissues, and in estrogen receptor alpha (ERalpha)-negative and ERalpha-positive breast tumors.
|
15084249 |
2004 |
Mammary Neoplasms
|
0.400 |
AlteredExpression
|
group |
LHGDN |
We determined mRNA levels of BCRP, LRP, MRP1, MRP2, and MDR1 in 59 primary breast tumor specimens of patients who received chemotherapy as first-line systemic treatment after diagnosis of advanced disease.
|
12576456 |
2003 |